de Jong PE - Search Results

1

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG; Chronic Kidney Disease Prognosis Consortium. Fox CS, et al. Among authors: de jong pe. Lancet. 2012 Nov 10;380(9854):1662-73. doi: 10.1016/S0140-6736(12)61350-6. Epub 2012 Sep 24. Lancet. 2012. PMID: 23013602 Free PMC article. Review.

2

Is the antiproteinuric effect of dipyridamole hemodynamically mediated?

de Jong PE, van der Meer J, van der Hem GK, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. Nephron. 1988;50(4):292-4. doi: 10.1159/000185190. Nephron. 1988. PMID: 3070413

3

The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.

de Zeeuw D, Navis GJ, Donker AJ, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. J Hypertens Suppl. 1983 Oct;1(1):93-7. J Hypertens Suppl. 1983. PMID: 6100614 Clinical Trial.

4

Absence of cross-reactivity between captopril and enalapril.

Navis GJ, de Jong PE, Kallenberg CG, de Monchy J, de Zeeuw D. Navis GJ, et al. Among authors: de jong pe, de monchy j, de zeeuw d. Lancet. 1984 May 5;1(8384):1017. doi: 10.1016/s0140-6736(84)92353-5. Lancet. 1984. PMID: 6143933 No abstract available.

5

The influence of indomethacin on renal concentrating and diluting capacity in sickle cell nephropathy.

De Jong PE, De Jong-van den Berg LT, De Zeeuw D, Donker AJ, Schouten H, Statius van Eps LW. De Jong PE, et al. Among authors: de jong van den berg lt, de zeeuw d. Clin Sci (Lond). 1982 Jul;63(1):53-8. doi: 10.1042/cs0630053. Clin Sci (Lond). 1982. PMID: 7083765

6

Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.

van Paassen P, de Zeeuw D, de Jong PE. van Paassen P, et al. Among authors: de jong pe, de zeeuw d. J Cardiovasc Pharmacol. 1995 Jul;26(1):39-45. doi: 10.1097/00005344-199507000-00007. J Cardiovasc Pharmacol. 1995. PMID: 7564363 Clinical Trial.

7

Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease?

Hemmelder MH, de Zeeuw D, Fidler V, de Jong PE. Hemmelder MH, et al. Among authors: de jong pe, de zeeuw d. Am J Kidney Dis. 1995 Jul;26(1):187-92. doi: 10.1016/0272-6386(95)90173-6. Am J Kidney Dis. 1995. PMID: 7611251

8

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Nephrol Dial Transplant. 1995;10(4):497-504. doi: 10.1093/ndt/10.4.497. Nephrol Dial Transplant. 1995. PMID: 7623991 Clinical Trial.

9

Renal function during antihypertensive treatment.

Janssen WM, de Zeeuw D, de Jong PE. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Lancet. 1995 Jul 15;346(8968):193. Lancet. 1995. PMID: 7661981 No abstract available.

10

Losartan in patients with renal insufficiency.

de Zeeuw D, Gansevoort RT, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. Can J Cardiol. 1995 Aug;11 Suppl F:41F-44F. Can J Cardiol. 1995. PMID: 7664217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

454 results

Search Page